Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butylbromide in First Stage Labour for High Risk Women
NCT03055390Phase 4Completed
- Sponsor
- Cairo University
- Start
- Feb 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscine butylbromide in labor, sponsored by Cairo University. Started Feb 2017; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
labor
Beyond the preview
Go deeper on NCT03055390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055390.